Zobrazeno 1 - 3
of 3
pro vyhledávání: '"ALI/ARDS, acute lung injury/acute respiratory distress syndrome"'
Autor:
George Frimpong Boafo, Zhongjian Chen, Marwa Ahmed Sallam, Qingqing Xiao, Makhloufi Zoulikha, Wei He
Publikováno v:
Acta Pharmaceutica Sinica. B
The use of small interfering RNAs (siRNAs) has been under investigation for the treatment of several unmet medical needs, including acute lung injury/acute respiratory distress syndrome (ALI/ARDS) wherein siRNA may be implemented to modify the expres
Publikováno v:
Biochemical Pharmacology
Graphical abstract
COVID-19 is an ongoing viral pandemic disease that is caused by SARS-CoV2, inducing severe pneumonia in humans. However, several classes of repurposed drugs have been recommended, no specific vaccines or effective therapeutic
COVID-19 is an ongoing viral pandemic disease that is caused by SARS-CoV2, inducing severe pneumonia in humans. However, several classes of repurposed drugs have been recommended, no specific vaccines or effective therapeutic
Autor:
Zoulikha M; Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China., Xiao Q; Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China., Boafo GF; Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China., Sallam MA; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt., Chen Z; Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China., He W; Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.; Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai 200443, China.
Publikováno v:
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2022 Feb; Vol. 12 (2), pp. 600-620. Date of Electronic Publication: 2021 Aug 12.